Cesarean scar pregnancies successfully treated with methotrexate

Acta Obstet Gynecol Scand. 2009;88(6):720-3. doi: 10.1080/00016340902883141.

Abstract

Three cases of cesarean scar pregnancy successfully treated with methotrexate are described. The diagnosis was confirmed by transvaginal sonographic examinations showing a well-formed gestational sac in the myometrium of the lower uterine segment. Initial treatment with a systemic injection of 50 mg of methotrexate was not sufficient, and multiple doses were required to obtain a complete remission in two cases. In a case with a beta-hCG level of more than 20,000 mIU/mL with a viable embryo in a gestational sac, a combination of systemic and local treatment with methotrexate was required. It took 7-11 weeks for the beta-hCG level to become undetectable and 12-17 weeks for the cesarean scar pregnancy mass to disappear completely.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortifacient Agents, Nonsteroidal / therapeutic use*
  • Abortion, Induced / methods
  • Adult
  • Cesarean Section / adverse effects*
  • Cicatrix / complications
  • Female
  • Humans
  • Methotrexate / therapeutic use*
  • Pregnancy
  • Pregnancy, Ectopic / diagnostic imaging
  • Pregnancy, Ectopic / drug therapy*
  • Ultrasonography

Substances

  • Abortifacient Agents, Nonsteroidal
  • Methotrexate